Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Xencor (XNCR) -- Ignore unavailable to you. Want to Upgrade?

To: fitzdad55 who wrote (69)	12/20/2014 11:26:16 AM
From: scaram(o)uche	1 Recommendation Recommended By fitzdad55 Read Replies (2) \| Respond to of 136

Here is my post from a day before the collaboration PR (pinned tweet, aspx coattails)...... Message 29855882 Here's the ASPX chart..... finance.yahoo.com And, frankly, I may have missed the major reason for the mystery rally.... the 17th was also the day where blinatumomab priced at $178K. Add that this pricing lead to conversations about CAR-T toxicity and complexities re. "manufacturing", scale-up and distribution. Not saying that you're wrong, just that there were extrinsic factors complicating picture. And addressing your thesis??.... SEC is the most highly inefficient regulatory agency that I know of (designed and maintained with intent, imo.... the agency sides with banks and avoids developing the tools with which piles of crooks could be jailed). Crooks everywhere know that they stand VERY little chance of being caught, and cheating is rampant. I agree with you insinuations. The U.S. investment world is filled with cheaters and thieves, and many SEC employees can't wait to get out and join the Wall Street party. Others, thankfully, are presumably working hard (with insufficient tools and resources) to clean up.